Pharmacotherapy for Sleep Disorders — MCQs
A 35-year-old male patient presents to surgery emergency with painful erection for past 7 hours. He has a history of mood disorder and was recently prescribed a medication by treating psychiatrist. Which is the likely offending drug?
Which of the following statements about ramelteon is false?
Which drug selectively acts on GABA-A receptors to induce sleep with minimal effects on sleep architecture?
Diazepam poisoning is treated by:
Which of the antidepressants is used in low doses as a hypnotic?
Drug of choice for night terrors:
The shortest-acting benzodiazepine is:
Modafinil is primarily used for the treatment of which of the following conditions?
Somnambulism is mostly seen in which age group?
What is the primary characteristic feature of Klein-Levin syndrome?
Pharmacotherapy for Sleep Disorders Indian Medical PG Practice Questions and MCQs
Question 1: A 35-year-old male patient presents to surgery emergency with painful erection for past 7 hours. He has a history of mood disorder and was recently prescribed a medication by treating psychiatrist. Which is the likely offending drug?
- A. Venlafaxine
- B. Tianeptine
- C. Trazodone (Correct Answer)
- D. Mirtazapine
Explanation: ***Trazodone*** - **Trazodone** is a commonly known antidepressant that can cause **priapism** as a side effect, especially at higher doses, due to its alpha-adrenergic blocking activity. [1] - The patient's presentation of a **painful erection lasting 7 hours** after starting a new psychiatric medication strongly points towards a drug-induced cause, for which trazodone is a well-established culprit. [1] *Venlafaxine* - **Venlafaxine** is an SNRI antidepressant that generally does not cause priapism as a recognized side effect. - Its adverse effect profile primarily includes nausea, insomnia, and sexual dysfunction (e.g., erectile dysfunction, anorgasmia), rather than prolonged erections. *Tianeptine* - **Tianeptine** is an atypical antidepressant that is not known to cause priapism. - It works by enhancing serotonin reuptake and is more commonly associated with side effects such as nausea, constipation, and dizziness. *Mirtazapine* - **Mirtazapine** is a tetracyclic antidepressant that works by blocking alpha-2 adrenergic receptors and certain serotonin receptors. - While it can cause sedation and weight gain, priapism is not a typical or recognized side effect of mirtazapine.
Question 2: Which of the following statements about ramelteon is false?
- A. Is a substrate of CYP1A2
- B. Approved for treatment of insomnia
- C. Has high addiction liability (Correct Answer)
- D. Agonist at MT1 and MT2 receptors
Explanation: ***Has high addiction liability*** - Ramelteon is a **melatonin receptor agonist** that does not bind to GABA receptors, distinguishing it from benzodiazepines and Z-drugs (zolpidem, eszopiclone, zaleplon). - Its mechanism of action leads to a **very low risk of abuse and dependence**, contrary to the statement. *Is a substrate of CYP1A2* - Ramelteon is extensively metabolized in the liver, primarily by **CYP1A2**, which is accurate. - This metabolic pathway can lead to drug interactions if co-administered with **CYP1A2 inhibitors** (e.g., fluvoxamine), which can significantly increase ramelteon concentrations. *Approved for treatment of insomnia* - Ramelteon is indeed indicated for the **treatment of insomnia**, particularly for difficulties with **sleep onset**. - It works by mimicking the action of **melatonin**, promoting the regulation of the sleep-wake cycle. *Agonist at MT1 and MT2 receptors* - Ramelteon acts as a **selective agonist** at the **melatonin MT1 and MT2 receptors** in the suprachiasmatic nucleus. - Activation of these receptors helps to modulate the **circadian rhythm**, thereby promoting sleep.
Question 3: Which drug selectively acts on GABA-A receptors to induce sleep with minimal effects on sleep architecture?
- A. Zolpidem (Correct Answer)
- B. Phenobarbitone
- C. Buspirone
- D. Diazepam
Explanation: ***Zolpidem*** - **Zolpidem** is a non-benzodiazepine hypnotic that selectively binds to the **omega-1 subtype of GABA-A receptors**, primarily mediating sedation. - This selective action results in sleep induction with **minimal disruption of normal sleep architecture**, making it preferable for insomnia. *Phenobarbitone* - **Phenobarbitone** is a barbiturate that non-selectively enhances GABA-A receptor activity, leading to global CNS depression. - It significantly **disturbs sleep architecture**, reducing REM sleep and slow-wave sleep, and carries a higher risk of dependence and overdose. *Buspirone* - **Buspirone** is an anxiolytic that acts as a partial agonist at **5-HT1A serotonin receptors** and has no direct activity at GABA-A receptors. - It treats generalized anxiety disorder but does **not induce sleep** and is not used as a hypnotic. *Diazepam* - **Diazepam** is a benzodiazepine that non-selectively binds to various subunits of the GABA-A receptor, enhancing GABAergic transmission. - While it induces sleep, it also **significantly alters sleep architecture** (reducing REM and slow-wave sleep) and has a longer half-life, increasing the risk of daytime sedation.
Question 4: Diazepam poisoning is treated by:
- A. Resins
- B. Hemofiltration
- C. Charcoal
- D. Flumazenil (Correct Answer)
Explanation: ***Flumazenil*** - **Flumazenil** is a **benzodiazepine receptor antagonist** that competitively binds to the benzodiazepine binding site on the GABA-A receptor, reversing the effects of diazepam. - It is used in cases of severe benzodiazepine overdose causing **respiratory depression** or **severe sedation**. *Resins* - **Resins**, such as **cholestyramine**, are typically used to bind toxins or drugs in the **gastrointestinal tract** that undergo enterohepatic recirculation. - They are generally not effective for reversing the central nervous system depression caused by a benzodiazepine overdose. *Hemofiltration* - **Hemofiltration** is a form of renal replacement therapy used to remove small and middle molecular weight substances from the blood. - While it can remove some drugs, **diazepam** is highly **lipophilic** and extensively **protein-bound**, making it poorly amenable to removal by hemofiltration. *Charcoal* - **Activated charcoal** is used to prevent the absorption of ingested toxins from the gastrointestinal tract. - It is effective when administered soon after ingestion but does not reverse the established effects of an absorbed drug like diazepam in an overdose situation.
Question 5: Which of the antidepressants is used in low doses as a hypnotic?
- A. fluoxetine
- B. fluvoxamine
- C. bupropion
- D. trazodone (Correct Answer)
Explanation: ***trazodone*** - **Trazodone** is an antidepressant that is frequently prescribed off-label at low doses as a **hypnotic** due to its potent **histamine H1 receptor antagonism** and **alpha-1 adrenergic blocking effects**, inducing sedation. - Its sedative properties differentiate it from other antidepressants that are primarily stimulating. *fluoxetine* - **Fluoxetine** is a **selective serotonin reuptake inhibitor (SSRI)** known for its **activating** effects, making it a poor choice for a hypnotic. - It is more likely to cause **insomnia** and agitation rather than sedation. *fluvoxamine* - **Fluvoxamine** is another **SSRI** primarily used for **obsessive-compulsive disorder (OCD)**. - Like other SSRIs, its primary action is not sedation, and it can sometimes lead to **sleep disturbances**. *bupropion* - **Bupropion** is a **norepinephrine-dopamine reuptake inhibitor (NDRI)** known for its **stimulating effects** and lack of sexual side effects. - It is often avoided in patients with **insomnia** due to its activating properties and is not used as a hypnotic.
Question 6: Drug of choice for night terrors:
- A. Tricyclic antidepressant
- B. Meprobamate
- C. Diazepam
- D. Clonazepam (Correct Answer)
Explanation: ***Clonazepam*** - **Clonazepam**, a benzodiazepine, is the **drug of choice** for night terrors due to its ability to suppress Stage 3 and 4 **slow-wave sleep**, where night terrors occur. - Its sedative and anxiolytic effects help to calm the patient and reduce the frequency and severity of these episodes. *Tricyclic antidepressant* - While some **tricyclic antidepressants** (TCAs) have sedative properties, they are generally not the first-line treatment for night terrors. - Their side effect profile and potential to alter other sleep stages make them less suitable than benzodiazepines for this specific parasomnia. *Meprobamate* - **Meprobamate** is an anxiolytic and sedative drug that is largely historical and has been replaced by safer and more effective alternatives like benzodiazepines. - It has a higher risk of dependence and side effects compared to modern treatments for sleep disorders. *Diazepam* - **Diazepam** is another benzodiazepine, but **clonazepam** is generally preferred for night terrors due to its longer half-life and specific efficacy in suppressing slow-wave sleep. - While diazepam could offer some relief, clonazepam is considered more effective for sustained management of this condition.
Question 7: The shortest-acting benzodiazepine is:
- A. Alprazolam
- B. Lorazepam
- C. Diazepam
- D. Midazolam (Correct Answer)
Explanation: ***Midazolam*** - **Midazolam** is known for its **rapid onset** and very **short duration of action**, making it suitable for procedures requiring quick sedation and recovery. - Its **high lipid solubility** allows for rapid entry into the CNS, and its rapid metabolism contributes to its short half-life. *Alprazolam* - **Alprazolam** has an intermediate half-life among benzodiazepines, typically around 11-15 hours, which is longer than midazolam. - It is primarily used for the short-term management of **anxiety disorders** and panic attacks. *Lorazepam* - **Lorazepam** has an intermediate to long half-life, ranging from 10 to 20 hours, and is often preferred for managing anxiety and insomnia due to its consistent efficacy. - It has a slower onset of action compared to midazolam and is metabolized via **glucuronidation**, which is less affected by liver dysfunction. *Diazepam* - **Diazepam** has a very long duration of action due to its **active metabolites** (like desmethyldiazepam), with a half-life extending up to 100 hours. - It is used for conditions requiring prolonged anxiolytic, sedative, or anticonvulsant effects, but not for its short duration.
Question 8: Modafinil is primarily used for the treatment of which of the following conditions?
- A. Narcolepsy (Correct Answer)
- B. Sexual dysfunction
- C. Depression
- D. Anxiety
Explanation: ***Narcolepsy*** - **Modafinil** is a **eugeroic** (wakefulness-promoting agent) specifically approved and widely used for the treatment of excessive daytime sleepiness associated with **narcolepsy**. - Its mechanism involves increasing **dopamine** and **norepinephrine** levels, and modulating **orexin** pathways, promoting alertness without significant psychomotor stimulation. *Sexual dysfunction* - While sometimes explored off-label for certain types of sexual dysfunction, **modafinil** is not a primary or approved treatment for this condition. - Primary treatments for sexual dysfunction often involve specific medications like **PDE5 inhibitors** or hormone therapy, depending on the cause. *Depression* - **Modafinil** is not a primary antidepressant, although it can be used as an **adjunctive therapy** in some cases to combat residual fatigue or hypersomnia associated with depression. - Standard treatment for depression involves **selective serotonin reuptake inhibitors (SSRIs)**, **serotonin-norepinephrine reuptake inhibitors (SNRIs)**, or other classes of antidepressants. *Anxiety* - **Modafinil** is a stimulant-like drug and can sometimes **exacerbate anxiety** in susceptible individuals due to its catecholaminergic effects. - Primary treatments for anxiety disorders include **selective serotonin reuptake inhibitors (SSRIs)**, **benzodiazepines** (for acute relief), and psychotherapy.
Question 9: Somnambulism is mostly seen in which age group?
- A. Adolescents
- B. All age groups
- C. Children (Correct Answer)
- D. Adults
Explanation: ***Correct Option: Children*** - Somnambulism (sleepwalking) is **most commonly seen in children**, with peak incidence between **4-12 years of age** - Approximately **15-40% of children** experience at least one episode of sleepwalking - Occurs during **slow-wave sleep (NREM stage 3)**, which is more prominent in childhood - Episodes typically **decrease and resolve by adolescence** as sleep architecture matures *Incorrect Option: Adolescents* - While sleepwalking can persist into adolescence, the **prevalence significantly decreases** during teenage years - Most children who sleepwalk stop by the time they reach adolescence *Incorrect Option: All age groups* - Though somnambulism can technically occur at any age, it is **NOT equally distributed** across age groups - The frequency is **significantly higher in children** compared to other age groups *Incorrect Option: Adults* - Adult-onset sleepwalking is **relatively rare (1-4% prevalence)** - When it occurs in adults, it may be associated with underlying conditions (medications, sleep deprivation, psychiatric disorders, or neurological conditions) - Childhood somnambulism has much higher prevalence rates
Question 10: What is the primary characteristic feature of Klein-Levin syndrome?
- A. Insomnia
- B. Anxiety
- C. Depression
- D. Hypersomnia (Correct Answer)
Explanation: ***Hypersomnia*** - **Hypersomnia** is the cardinal and primary characteristic feature of Klein-Levin syndrome, characterized by recurrent episodes of excessive sleepiness lasting days to weeks. - During these episodes, individuals may sleep for **16 to 20 hours a day** and are extremely difficult to awaken. - Episodes are often accompanied by **cognitive disturbances** (confusion, derealization), **behavioral changes** (apathy, hyperphagia, hypersexuality), but **hypersomnia remains the defining feature**. - Normal functioning returns between episodes. *Insomnia* - **Insomnia** (difficulty falling or staying asleep) is the opposite of the key symptom seen in Klein-Levin syndrome. - Klein-Levin syndrome is a disorder of excessive sleep, not sleep deprivation. *Anxiety* - **Anxiety** may occur as a secondary feature or during the distress of episodes, but it is not the primary characteristic feature. - The core pathology manifests as profound sleep disturbance, not an anxiety disorder. *Depression* - **Depression** is sometimes observed during or after episodes of Klein-Levin syndrome, but it is not the primary defining feature. - The diagnostic hallmark is the **recurrent hypersomnia with associated cognitive and behavioral symptoms**, not mood disturbance.
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free